The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer | Zendy

Makito Mizunuma | Zendy; Yoshihito Yokoyama | Zendy; Masayuki Futagami | Zendy; Masahiko Aoki | Zendy; Yoshihiro Takai | Zendy; Hideki Mizunuma | Zendy

Open Access

The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer

Author(s) -

Makito Mizunuma,

Yoshihito Yokoyama,

Masayuki Futagami,

Masahiko Aoki,

Yoshihiro Takai,

Hideki Mizunuma

Publication year - 2015

Publication title -

international journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.06

H-Index - 62

eISSN - 1437-7772

pISSN - 1341-9625

DOI - 10.1007/s10147-015-0807-6

Subject(s) - medicine , neutrophil to lymphocyte ratio , surgical oncology , oncology , cervical cancer , radiation therapy , multivariate analysis , cancer , gastroenterology , lymphocyte

The aim of this study was to investigate the prognostic role of the pretreatment neutrophil-to-lymphocyte ratio (NLR) as a predictive marker prior to treatment of cervical cancer with radiation therapy (RT) alone or concurrent chemoradiation therapy (CCRT).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research